Stay updated on Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov record for this mesothelioma trial is displayed with its study design, eligibility criteria, outcome measures, participating locations, and study documents.
    Difference
    89%
    Check dated 2026-11-08T11:21:46.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0. The study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T12:17:00.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A banner was added announcing NIH website updates and a transition from using “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    1%
    Check dated 2026-10-25T12:35:33.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.1 to v3.7.2; the study record remains unavailable on the error page.
    Difference
    0.2%
    Check dated 2026-10-18T13:31:44.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The site footer revision advances from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T14:58:16.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    403 Forbidden page now appears, replacing the normal study content and navigation. This blocks access to the trial details and locations.
    Difference
    21%
    Check dated 2026-09-20T19:54:41.000Z thumbnail image

Stay in the know with updates to Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial page.